Trial Profile
Effect of Cabergoline on rheumatiod Arthritis patient.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 13 Sep 2016
Price :
$35
*
At a glance
- Drugs Cabergoline (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 12 Oct 2011 New trial record
- 21 Apr 2010 Recruitment complete, according to the Iranian Registry of Clinical Trials